As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

The White House is considering Erica Schwartz to lead the CDC amid ongoing leadership changes, with additional senior appointments also und...

The FDA will now consider Moderna's mRNA flu vaccine application after a dispute over clinical trial design. Moderna agreed to seek full ap...

The US Food and Drug Administration will now review Moderna's influenza vaccine. This comes after an initial refusal due to trial design is...

Moderna has withdrawn its application for a combination flu and COVID vaccine, awaiting efficacy data from a late-stage influenza shot tria...

The US Food and Drug Administration changes Covid-19 vaccine approval process. Access to seasonal boosters is restricted for healthy indivi...

In a request to the Food and Drug Administration (FDA), Boston-based biotech has requested that omicron shots be approved for teenagers age...

In early August, a Wall Street Journal report stated that India was in talks to buy 50 million doses of Pfizer and German partner BioNTech ...

The vaccine made by Pfizer and its partner BioNTech now carries the strongest endorsement from the Food and Drug Administration, which has ...

Around 52% of the country is fully vaccinated, but health authorities have hit a wall of vaccine hesitant people, impeding the national cam...

The two pharma companies plan to submit data in support of the application "on a rolling basis over the coming weeks" to the Food and Drug ...

In February, some scientists and lawmakers suggested using a one-dose regimen for all coronavirus vaccines approved in the US, after certai...

The FDA had not yet authorized emergency use of the vaccine, a Bloomberg reporter said on Twitter, citing the agency. FDA and Moderna did n...

An emergency use authorisation (EUA) is short of a full approval. Pfizer would have to file a separate application for full FDA approval fo...

Several scientists have raised doubts about the robustness of results showing the shot was 90% effective in a sub-group of trial participan...

During a health crisis, the FDA can loosen its normal scientific standards.

Murthy in the past has advocated a science-based approach to the pandemic and often cautioned against politics and politicians dictating pa...